After scientific breakthrough: digid seeks FDA approval for its rapid corona antigen test
At the Helmholtz Centre for Infection Research (HZI), scientists have succeeded for the first time in detecting SARS-CoV-2 viruses using the revolutionary Cantisense™ technology from Digital Diagnostics AG. Application for approval of the Digid Cantisense™ SARS-CoV-2 Test by the FDA has been submitted. With the new digid Cantisense™ SARS-CoV-2 test, corona infections can be reliably detected within minutes at the point-of-care. Delivery of the first point-of-care tests is planned for July.